The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other factors. Healthcare providers often start with one medication but may need ...

In severe conditions, some medication must be used with caution. The concern is that many medications have not been ... These conditions include insomnia, RLS, narcolepsy, and parasomnias. The safety ...

Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other ...

The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

People who live with narcolepsy ... Classic treatment options Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as ...

The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments ...

According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate (PTSR ... GlobalData, the leading provider of industry intelligence, provided the underlying data, ...

Over-the-counter (OTC) pain medications are often used to ease symptoms of a migraine attack that’s already begun. Let’s dig deeper into the different types of OTC medications used for ...

Avadel Pharmaceuticals expects its narcolepsy treatment Lumryz to drive strong revenue growth in the fourth quarter and into 2025, preliminary earnings show.